Lead author, Dr Jennifer Summers, along with several members of the Medical Statistics team, Mercy Ofuya, Dr Yanzhong Wang & Professor Janet Peacock, were published in Applied Health Economics and Health Policy:
The study assessed the geko device; a small neuromuscular electrostimulation device that may reduce the risk of venous thromboembolism (VTE) and could be used in people for whom other methods of prophylaxis are impractical or contraindicated and who have a high risk of VTE.
The gekoTM device: http://www.gekodevices.com
The authors estimated cost savings for the gekoTM device in patients at high risk of VTE compared with no prophylaxis was £197 per patient.
In June 2014, the geko device was recommended for adoption within the NHS for people who have a high risk of VTE and for whom other mechanical and pharmacological methods of prophylaxis are impractical or contraindicated.
MedStats news 